Bisphosphonate Use and Prevalence of Valvular and Vascular Calcification in Women MESA (The Multi-Ethnic Study of Atherosclerosis)

J Am Coll Cardiol. 2010 Nov 16;56(21):1752-9. doi: 10.1016/j.jacc.2010.05.050.

Abstract

Objectives: the aim of this study was to determine whether nitrogen-containing bisphosphonate (NCBP) therapy is associated with the prevalence of cardiovascular calcification.

Background: cardiovascular calcification correlates with atherosclerotic disease burden. Experimental data suggest that NCBP might limit cardiovascular calcification, which has implications for disease prevention.

Methods: the relationship of NCBP use to the prevalence of aortic valve, aortic valve ring, mitral annulus, thoracic aorta, and coronary artery calcification (AVC, AVRC, MAC, TAC, and CAC, respectively) detected by computed tomography was assessed in 3,710 women within the MESA (Multi-Ethnic Study of Atherosclerosis) with regression modeling.

Results: Analyses were age-stratified, because of a significant interaction between age and NCBP use (interaction p values: AVC p < 0.0001; AVRC p < 0.0001; MAC p = 0.002; TAC p < 0.0001; CAC p = 0.046). After adjusting for age; body mass index; demographic data; diabetes; smoking; blood pressure; cholesterol levels; and statin, hormone replacement, and renin-angiotensin inhibitor therapy, NCBP use was associated with a lower prevalence of cardiovascular calcification in women ≥ 65 years of age (prevalence ratio: AVC 0.68 [95% confidence interval (CI): 0.41 to 1.13]; AVRC 0.65 [95% CI: 0.51 to 0.84]; MAC 0.54 [95% CI: 0.33 to 0.93]; TAC 0.69 [95% CI: 0.54 to 0.88]; CAC 0.89 [95% CI: 0.78 to 1.02]), whereas calcification was more prevalent in NCBP users among the 2,181 women <65 years of age (AVC 4.00 [95% CI: 2.33 to 6.89]; AVRC 1.92 [95% CI: 1.42 to 2.61]; MAC 2.35 [95% CI: 1.12 to 4.84]; TAC 2.17 [95% CI: 1.49 to 3.15]; CAC 1.23 [95% CI: 0.97 to 1.57]).

Conclusions: among women in the diverse MESA cohort, NCBPs were associated with decreased prevalence of cardiovascular calcification in older subjects but more prevalent cardiovascular calcification in younger ones. Further study is warranted to clarify these age-dependent NCBP effects.

Publication types

  • Comparative Study
  • Multicenter Study
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Asian
  • Atherosclerosis / chemically induced
  • Atherosclerosis / diagnostic imaging
  • Atherosclerosis / ethnology*
  • Black or African American
  • Bone Density Conservation Agents / adverse effects
  • Calcinosis / chemically induced
  • Calcinosis / diagnostic imaging
  • Calcinosis / ethnology*
  • Diphosphonates / adverse effects*
  • Female
  • Follow-Up Studies
  • Heart Valve Diseases / chemically induced
  • Heart Valve Diseases / ethnology*
  • Hispanic or Latino
  • Humans
  • Middle Aged
  • Prevalence
  • Prognosis
  • Radiography
  • Retrospective Studies
  • Risk Factors
  • United States / epidemiology
  • Vascular Diseases / chemically induced
  • Vascular Diseases / diagnostic imaging
  • Vascular Diseases / ethnology*
  • White People

Substances

  • Bone Density Conservation Agents
  • Diphosphonates